SNX

154.49

+2.19%↑

PII

64.53

-1.65%↓

NWL

3.22

+2.55%↑

BFLY.US

2.24

+0.45%↑

SNX

154.49

+2.19%↑

PII

64.53

-1.65%↓

NWL

3.22

+2.55%↑

BFLY.US

2.24

+0.45%↑

SNX

154.49

+2.19%↑

PII

64.53

-1.65%↓

NWL

3.22

+2.55%↑

BFLY.US

2.24

+0.45%↑

SNX

154.49

+2.19%↑

PII

64.53

-1.65%↓

NWL

3.22

+2.55%↑

BFLY.US

2.24

+0.45%↑

SNX

154.49

+2.19%↑

PII

64.53

-1.65%↓

NWL

3.22

+2.55%↑

BFLY.US

2.24

+0.45%↑

Home・Elenco Azioni・Nu Skin Enterprises Inc

Nu Skin Enterprises Inc

Aperta

9.91 7.95

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

9.15

Massimo

10.01

Metriche Chiave
By Trading Economics
Entrata	-86M 21M
Vendite	22M 386M
P/E Media del settore	5.271 17.41
Rendimento da dividendi	2.24
Margine di Profitto	5.469
Dipendenti	3,100
EBITDA	-109M 43M

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	2.24% 7.66%
Prossima data del Dividendo	10 dic 2025
Prossima data del' Ex Dividendo	28 nov 2025

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	118M 530M
Apertura precedente	1.96
Chiusura precedente	9.91

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

5.78 / 6.16 Supporto e resistenza

Nu Skin Enterprises Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 nov 2025, 21:36 UTC

Utili

Australia's ANZ Bank Posts 10% Drop in Annual Profit -- Update

9 nov 2025, 21:22 UTC

Utili

Australia's ANZ Bank Posts 10% Drop in Annual Profit

10 nov 2025, 00:00 UTC

Discorsi di Mercato

India Inflation Poised to Hit New Low -- Market Talk

9 nov 2025, 23:47 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

9 nov 2025, 23:35 UTC

Discorsi di Mercato

Gold Edges Higher Amid Signs of U.S. Economic Weakness -- Market Talk

9 nov 2025, 21:05 UTC

Utili

ANZ FY Total Operating Expenses A$12.88B Vs. A$11.465B Pro Forma>ANZ.AU

9 nov 2025, 21:04 UTC

Utili

ANZ FY Operating Expenses A$11.85B Ex-Significant Items>ANZ.AU

9 nov 2025, 21:03 UTC

Utili

ANZ 2H Net Interest Margin 1.54% Vs. 1.56% in 1H>ANZ.AU

9 nov 2025, 20:49 UTC

Utili

ANZ FY Australia Retail Deposits Up 6% on Year>ANZ.AU

9 nov 2025, 20:49 UTC

Utili

ANZ FY Australia Home Loan Lending Up 5% on Year>ANZ.AU

9 nov 2025, 20:45 UTC

Utili

ANZ FY Average Customer Deposits A$760.8B Vs. A$669.4B>ANZ.AU

9 nov 2025, 20:45 UTC

Utili

ANZ FY Average Gross Loans & Advances A$833.6B Vs. A$733.8B>ANZ.AU

9 nov 2025, 20:42 UTC

Utili

ANZ FY Results Include Full-Year Benefit of Suncorp Bank Acquisition>ANZ.AU

9 nov 2025, 20:42 UTC

Utili

ANZ FY Net Interest Margin 1.55% Vs. 1.57%>ANZ.AU

9 nov 2025, 20:41 UTC

Utili

ANZ FY Common Equity Tier 1 Ratio 12.0% Vs. 12.2%>ANZ.AU

9 nov 2025, 20:41 UTC

Utili

ANZ FY Net Profit Includes A$1.11B of Notable Items>ANZ.AU

9 nov 2025, 20:39 UTC

Utili

ANZ FY Credit Impairment Charge A$441M Vs. A$406M>ANZ.AU

9 nov 2025, 20:39 UTC

Utili

ANZ FY Rev A$22.19B Vs. A$20.55B >ANZ.AU

9 nov 2025, 20:38 UTC

Utili

ANZ Keeps Dividend at A$0.83 >ANZ.AU

9 nov 2025, 20:38 UTC

Utili

ANZ FY Cash Profit A$5.79B Vs. A$6.725B>ANZ.AU

9 nov 2025, 20:38 UTC

Utili

ANZ FY Net A$5.89B Vs. Net A$6.535B >ANZ.AU

8 nov 2025, 13:10 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov 2025, 03:50 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov 2025, 03:41 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov 2025, 03:07 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov 2025, 22:36 UTC

Utili

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov 2025, 22:22 UTC

Utili

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov 2025, 22:03 UTC

Utili

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov 2025, 22:03 UTC

Utili

Constellation Software 3Q Net $210M >CSU.T

7 nov 2025, 22:03 UTC

Utili

Constellation Software 3Q EPS $9.89 >CSU.T

Confronto tra pari

Modifica del prezzo

Nu Skin Enterprises Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 0 che hanno fornito valutazioni azionarie a Nu Skin Enterprises Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

5.78 / 6.16Supporto e resistenza

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.